Olympic Cards (534190)
Fast GrowerScore breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹3.79 |
| Market Cap | ₹6.71 Cr |
| P/E Ratio | 13.81 |
| ROCE | -9.91% |
| ROE | 10.5% |
| Dividend Yield | 0% |
| Profit Growth | 392.92% |
| Debt/Equity | — |
| Sales Growth | 48.02% |
| 52-Week Range | ₹2.51 — ₹3.79 |
| Sector | Consumer Durables |
| Book Value | ₹2.05 |
Strengths
- Sales growth of 48% shows momentum in the leisure products segment.
- Piotroski F-Score of 6/9 indicates some improvement in financial health.
- Book value of ₹2.05 provides a partial asset cushion against the ₹3.79 price.
- Profit growth of 392% has dramatically expanded reported earnings, even if quality needs scrutiny.
Concerns
- ROCE is -9.91%, meaning core operations are destroying capital.
- Latest quarter shows a 100% net margin (₹3 Cr profit on ₹3 Cr sales), which is likely non-recurring or extraordinary.
- No dividend and no promoter holding disclosure reduce transparency and shareholder alignment.
- Tiny ₹7 Cr market cap implies high volatility, illiquidity, and speculative character.
AI Analysis
Looking at Olympic Cards, I see the classic illusion of a bargain. The price is ₹3.79, the market cap a minuscule ₹7 Cr, and the trailing P/E of 13.81 seems to scream 'cheap.' But Graham taught me that numbers are only as trustworthy as the earnings behind them. Sales grew 48%, and profit jumped 393%—yet the latest quarter shows ₹3 Cr of sales and ₹3 Cr of net profit. A 100% net margin is not a business; it is an event. Perhaps an exceptional gain or a one-time order. That immediately makes the P/E and the 0.04 PEG unreliable. The core operations tell a different story: ROCE is -9.91%, meaning the company earns less than nothing on its capital. With a book value of ₹2.05, I'm being asked to pay 1.85 times for assets that aren't generating operating returns. Even ROE of 10.5% looks flattering only because equity is thin. This is a leisure products micro-cap, likely in playing cards, a commodity-like business with no pricing power and no moat. There's no dividend to reward patient waiting, and promoter holding is not disclosed—so I can't judge alignment. The Piotroski F-Score of 6 suggests some improvement, but that's a crib sheet, not a deep analysis. In the end, a fast-growing company with negative capital returns and a single beautiful quarter is a speculation. I prefer a mediocre business at a wonderful price—but this isn't obviously wonderful. I'll wait for several quarters of consistent cash profits, positive ROCE, and clearer insider ownership before I call it an investment. Put it on the watch list, not in the portfolio.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer